Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines

Cancer Gene Therapy

Volumn 6, Issue 2, 1999, Pages 163-172

  Liu, Ta Jen ^a   Wang, Mary ^a   Breau, Randall L ^a   Henderson, Ying ^a   El Naggar, Adel K ^b   Steck, Kimberly D ^b   Sicard, Michael W ^a   Clayman, Gary L ^a  

^a Departments of Head and Neck Surgery   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Cancer gene therapy; E2F 1; P53; Retinoblastoma; Squamous cell carcinomas

Indexed keywords

CARRIER PROTEIN; CELL CYCLE PROTEIN; CHLORAMPHENICOL ACETYLTRANSFERASE; DNA BINDING PROTEIN; DNA FRAGMENT; E2F1 PROTEIN, HUMAN; E2F1 PROTEIN, MOUSE; RETINOBLASTOMA BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1;

ADENOVIRUS; ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIVISION; DRUG EFFECT; EXPERIMENTAL NEOPLASM; GENETICS; HEAD AND NECK TUMOR; HUMAN; METABOLISM; MOUSE; NICK END LABELING; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TIME; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA FRAGMENTATION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; TIME FACTORS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033091228     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700007     Document Type: Article

References (29)

1. American Cancer Society. Cancer Facts and Figures. Washington, DC: American Cancer Society; 1990. Publication 90-425 M no. 5008-LE.
2. dayman GL. Basic science reviews: gene therapy for head and neck cancer. Head Neck. 1995;17:535-541.
3. Kasid A, Morecki S, Aebersold P, et al. Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. Proc Natl Acad Sci USA. 1990;87:473-477.
4. O’Malley BW, Jr, Chen SH, Schwartz MR, Woo SL. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res. 1995;55:1080-1085.
5. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA. 1992;89:4495-4499.
6. Wang J, Bucana CD, Roth JA, Zhang W-W. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53. Cancer Gene Ther. 1995;2:9-17.
7. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang W-W, Owen-Schaub LB, Roth JA. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 1994;54: 2287-2291.
8. Liu T-J, El-Naggar AK, McDonnell TJ, et al. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 1995;55:3117-3122.
9. Boise LH, Gonzalez-Garcia M, Postema CE, et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74:597-608.
10. Oltva ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimer-izes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-619.
11. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 1995;80:285-291.
12. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey AA. cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell. 1992;70:337-350.
13. Helin K, Wu CL, Fattaey AR, et al. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative mws-activation. Genes Dev. 1993;7:1850-1861.
14. Slansky JE, Li Y, Kaelin WG, Farnham PJ. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol. 1993;13:1610-1618.
15. Kowalik TF, De Gregori J, Schwarz JK, Nevins JR. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol. 1995;69: 2491-2500.
16. Liu T-J, Zhang W-W, Taylor DL, Roth JA, Goepfert H, Clayman GL. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 1994;54: 3662-3667.
17. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, Walker, JM, eds. Methods in Molecular Biology, Vol. 7. Clifton, New Jersey: Humana Press; 1991: 109-128.
18. Huyghe BG, Liu X, Sutjipto S, et al. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum Gene Ther. 1995;6:1403-1416.
19. Shan B, Chang CY, Jones D, Lee W-H. The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol Cell Biol, 1994;14:299-309.
20. Clayman GL, El-Naggar AK, Roth JA, et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 1995;55:1-6.
21. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992;69: 119-128.
22. White E, Cipriani R, Sabbatini P, Denton A. Adenovirus E1B 19-kiIodaIton protein overcomes the cytotoxicity of El A proteins. J Virol. 1991;65:2968-2978.
23. Lees E, Faha B, Dulic V, Reed SI, Harlow E. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with pi07 and E2F in a temporally distinct manner. Genes Dev. 1992;6: 1874-1885.
24. Krek W, Xu G, Livingston DM. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell. 1995;83:1149-1158.
25. Hsieh J-K, Fredersdorf S, Kouzarides T, Martin K, Lu X. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 1997; 11: 1840-1852.
26. Hunt KK, Deng J, Liu T-J, Wilson-Heiner M, et al. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res. 1997;57:4722-4726.
27. Field SJ, Tsai F-Y, Kuo F, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell. 1996; 85:549-561.
28. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson, NJ. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell. 1996;85:537-548.
29. Mobley SR, Clayman GL. The promise of gene therapy in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 1996;4:82-87.